FDA authorizes serial screening tests for asymptomatic people
![FDA product update](/sites/default/files/styles/900x400/public/2018-04/FDA%20product%20update.jpg?itok=TkhlK6rs)
The Food and Drug Administration this week authorized several SARS-CoV-2 serial screening tests for asymptomatic individuals. They include two over-the-counter tests for use at home; one over-the-counter test for use at home with a telehealth proctor; one over-the-counter test for point-of-care settings; and one prescription test for point-of-care settings.
FDA previously authorized the tests for individuals with COVID-19 symptoms.
“The addition of the OTC and POC tests for screening will give schools, workplaces, communities and others several options for serial screening tests that are accurate and reliable,” FDA said.
Related News Articles
Headline
The Centers for Disease Control and Prevention's COVID-19 data tracker shows an 18.1% test positivity rate for the week ending Aug. 10, the highest it has been…
Headline
The Centers for Disease Control and Prevention Aug. 13 issued an advisory alerting of an uptick of cases of parvovirus B19 across the U.S. Parvovirus B19 is a…
Blog
The RAND Corporation recently released the fifth iteration of its biannual hospital price report. The AHA has previously highlighted significant flaws with…
Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19…